At BRI, innovation isn’t just a buzzword — it’s a commitment to making life better for people living with immune system diseases. Innovation means not just looking for better treatments, but asking exactly why a disease happens, and how we can stop it before it starts. It’s about looking for answers in unexpected places and building new tools to solve long-standing problems. It means bringing together experts across different specialties to do together what they cannot do alone. It’s about thinking differently, trying new approaches, and asking bold questions; all in the pursuit of our vision of a healthy immune system for everyone.
We invite you to join us for the opportunity to learn more about the impact of innovation from BRI President Jane Buckner, MD, and a panel of BRI scientists led by Adam Lacy-Hulbert, PhD, director of BRI’s Center for Systems Immunology, including Allyson Byrd, PhD, Jessica Hamerman, PhD, Eddie James, PhD, and Cate Speake, PhD. You’ll hear firsthand about advances led by our scientists and discover how we’re using immunology to change lives.
At the event, BRI scientists will discuss our latest work in:
- Examining the role of the gut microbiome in immune system disease development and treatment.
- Studying how environmental exposures like the sun, viruses, chemicals and air quality affect the development and progression of autoimmune diseases.
- Creating lab-grown beta cells to study type 1 diabetes.
- Discovering more about the function of an autoantibody present in people with lupus, which may lead to improved diagnosis and treatment of the disease.
- Screening for autoimmune diseases like type 1 diabetes, rheumatoid arthritis and celiac disease.
The evening will include ample time for audience Q&A with our investigators; bites and beverages will be served.